Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)
- 1 February 2006
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 159 (3) , 169-179
- https://doi.org/10.1016/j.cbi.2005.11.002
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats1Transplantation, 2004
- Calcein accumulation as a fluorometric functional assay of the multidrug transporterPublished by Elsevier ,2002
- The behaviour of doramectin in the gastrointestinal tract, its secretion in bile and pharmacokinetic disposition in the peripheral circulation after oral and intravenous administration to sheepJournal of Veterinary Pharmacology and Therapeutics, 2000
- Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.Journal of Clinical Investigation, 1998
- Expression of the multidrug resistance‐associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cellsBritish Journal of Haematology, 1996
- Decreased biotolerability for ivermectin and cyclosporin a in mice exposed to potent P‐glycoprotein inhibitorsInternational Journal of Cancer, 1995
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- ATP‐dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletionFEBS Letters, 1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993